Negative Pressure Wound Therapy in Diabetic Foot Ulcers: What Current Evidence Tells Us
Diabetic foot ulcers (DFUs) remain one of the most challenging complications of diabetes, with a lifetime risk of approximately 19–34%. Roughly 20% of moderate or severe DFUs eventually result in some level of amputation, and outcomes after major lower-extremity amputation are sobering. Among the adjunctive technologies developed to improve healing, negative pressure wound therapy (NPWT) has been studied extensively. This post reviews recent peer-reviewed evidence and international guidelines on NPWT in DFU care, including mechanism, clinical effectiveness, indications, and limitations.
How NPWT Works
NPWT applies controlled sub-atmospheric pressure—typically between –75 and –125 mmHg—to a sealed wound through an open-cell foam or gauze interface. The biological effects are multifactorial: reduced interstitial edema, clearance of excess exudate and inflammatory mediators, wound-edge contraction (macrostrain), and cellular-level microstrain that stimulates fibroblast proliferation, angiogenesis, and granulation tissue formation. Translational research has identified molecular pathways involved, including upregulation of PRDX2 in wound margin tissue and modulation of microRNAs such as miR-155 (Wang et al., Scientific Reports, 2023). Earlier mechanistic work also documented mobilization of endothelial progenitor cells, supporting NPWT’s role in neovascularization.
Clinical Evidence: Healing Rates and Time to Closure
The clinical evidence base for NPWT in DFUs has grown considerably. A landmark multicenter randomized controlled trial by Armstrong and Lavery, published in The Lancet (2005) and subsequently expanded in follow-up analyses, demonstrated that patients treated with NPWT after partial diabetic foot amputation had higher rates of complete wound closure (56%) compared with standard moist wound therapy (39%) over 16 weeks, with shorter time to granulation tissue and a lower rate of secondary amputation.
More recent syntheses have reinforced these findings. A 2024 meta-analysis in the International Wound Journal reported a significant improvement in wound healing rate (RR 1.46, 95% CI 1.22–1.76) and a reduction in amputation rate (RR 0.69, 95% CI 0.50–0.96) with NPWT versus conventional dressings. A 2025 systematic review pooling 11 trials and 1,117 patients found higher odds of ulcer healing (OR 2.07, 95% CI 1.09–3.05), a mean reduction of approximately 22 days in time to healing, and faster granulation, with no significant increase in adverse events.
Guideline-Based Indications
The 2023 update of the International Working Group on the Diabetic Foot (IWGDF) guidelines on interventions to enhance healing of foot ulcers in people with diabetes provides nuanced recommendations on NPWT (Chen et al., Diabetes/Metabolism Research and Reviews, 2024). The guideline panel issued a conditional recommendation in favor of NPWT as an adjunct to standard care for postsurgical diabetes-related foot wounds—such as those following partial foot amputation or surgical debridement—when best standard of care has not achieved healing and resources are available. By contrast, the panel did not recommend NPWT for non-surgical chronic DFUs, citing limited evidence of incremental benefit beyond optimized standard care in that setting.
The companion 2023 IWGDF/IDSA guideline on diabetes-related foot infections similarly advises against NPWT—with or without instillation—as a primary treatment for active foot infection. NPWT is therefore best understood as an adjunct used after appropriate sharp debridement, infection control, vascular assessment, and offloading, rather than a substitute for these foundational interventions.
Practical Considerations and Limitations
Several practical factors influence outcomes. The wound bed must be adequately debrided and free of necrotic tissue, and frank ischemia should be addressed first—NPWT does not compensate for inadequate perfusion. Contraindications include exposed major vessels, untreated osteomyelitis, malignancy in the wound, and necrotic eschar. Reported adverse events are generally minor (periwound maceration, pain at dressing changes, bleeding), at rates comparable to advanced moist wound therapies. Cost-effectiveness varies by setting, but several analyses suggest that in appropriately selected post-amputation patients, NPWT can shorten hospitalization and reduce reoperation, though evidence quality is heterogeneous.
Key Takeaways
Current evidence supports NPWT as a useful adjunct for selected diabetic foot wounds, particularly postsurgical and post-amputation wounds, where it has been associated with higher healing rates, faster granulation, and lower secondary amputation rates compared with standard dressings. International guidelines reserve a conditional recommendation for these indications and advise against routine use in non-surgical chronic DFUs or active foot infections. As with all DFU therapies, optimal outcomes depend on integration with debridement, infection management, vascular optimization, glycemic control, and pressure offloading.
References
- Armstrong DG, Lavery LA, for the Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. The Lancet. 2005;366(9498):1704–1710.
- Chen P, Vilorio NC, Dhatariya K, et al. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3644.
- Senneville É, Albalawi Z, van Asten SA, et al. IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections (IWGDF/IDSA 2023). Clinical Infectious Diseases. 2023.
- Zhang Y, Lin Y, Liu X, et al. The effect of negative pressure wound therapy on the outcome of diabetic foot ulcers: a meta-analysis. International Wound Journal. 2024;21(5):e14886.
- Mihai M, et al. Comparative Efficacy of Negative Pressure Wound Therapy and Conventional Treatments in the Management of Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2025;14(22):8051.
- Wang Y, et al. Negative pressure wound therapy promotes wound healing of diabetic foot ulcers by up-regulating PRDX2 in wound margin tissue. Scientific Reports. 2023;13:15376.
- Liu Z, Dumville JC, Hinchliffe RJ, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database of Systematic Reviews. 2018, Issue 10. CD010318.
Comments
